Andrew M. Ackrill

1.4k total citations
17 papers, 1.1k citations indexed

About

Andrew M. Ackrill is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Andrew M. Ackrill has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Andrew M. Ackrill's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Andrew M. Ackrill is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Andrew M. Ackrill collaborates with scholars based in United Kingdom, United States and Switzerland. Andrew M. Ackrill's co-authors include George R. Stark, Ian M. Kerr, Graham R. Foster, Patrick Marcellin, Stephanos J. Hadziyannis, K. Rajender Reddy, Paul J. Pockros, Bernard Willems, Peter Ferenci and Timothy R. Morgan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Gastroenterology.

In The Last Decade

Andrew M. Ackrill

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew M. Ackrill United Kingdom 13 696 677 255 219 130 17 1.1k
Noriyoshi Kuzushita Japan 21 563 0.8× 697 1.0× 521 2.0× 139 0.6× 200 1.5× 36 1.3k
Bettina Langhans Germany 17 420 0.6× 562 0.8× 470 1.8× 149 0.7× 117 0.9× 46 1.0k
Glenn B. Knight United States 14 720 1.0× 905 1.3× 107 0.4× 114 0.5× 281 2.2× 18 1.4k
Hideharu Harada Japan 13 984 1.4× 1.3k 1.9× 104 0.4× 163 0.7× 260 2.0× 26 1.6k
C. Bréchot France 15 919 1.3× 861 1.3× 68 0.3× 163 0.7× 220 1.7× 55 1.2k
Seishin Azuma Japan 17 495 0.7× 589 0.9× 233 0.9× 74 0.3× 201 1.5× 37 930
A Alfarano Italy 16 428 0.6× 344 0.5× 239 0.9× 117 0.5× 292 2.2× 31 1.2k
David Apelian United States 16 1.3k 1.9× 1.3k 1.9× 343 1.3× 315 1.4× 253 1.9× 36 1.9k
S. Koi Japan 8 812 1.2× 848 1.3× 141 0.6× 288 1.3× 561 4.3× 11 1.7k
Nadia Alatrakchi United States 18 345 0.5× 300 0.4× 447 1.8× 181 0.8× 99 0.8× 27 1.1k

Countries citing papers authored by Andrew M. Ackrill

Since Specialization
Citations

This map shows the geographic impact of Andrew M. Ackrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Ackrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Ackrill more than expected).

Fields of papers citing papers by Andrew M. Ackrill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Ackrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Ackrill. The network helps show where Andrew M. Ackrill may publish in the future.

Co-authorship network of co-authors of Andrew M. Ackrill

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Ackrill. A scholar is included among the top collaborators of Andrew M. Ackrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Ackrill. Andrew M. Ackrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Bernaards, Coen, Rohit Kulkarni, Ethan R. Badman, et al.. (2014). Understanding the effect of the HCV polymerase inhibitor mericitabine on early viral kinetics in the phase 2 JUMP‐C and PROPEL studies. British Journal of Clinical Pharmacology. 78(3). 533–542. 1 indexed citations
3.
4.
Reddy, K. Rajender, Sugantha Govindarajan, Patrick Marcellin, et al.. (2007). Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon α‐2a plus ribavirin. Journal of Viral Hepatitis. 15(2). 129–136. 40 indexed citations
5.
Jensen, Donald M., Timothy R. Morgan, Patrick Marcellin, et al.. (2006). Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy. Hepatology. 43(5). 954–960. 356 indexed citations
6.
7.
Laxton, Carl, et al.. (2001). Selection of HCV NS5A quasispecies during IFN therapy in patients with chronic HCV.. Digestive Diseases and Sciences. 46(7). 1399–1408. 6 indexed citations
8.
Laxton, Carl, et al.. (1999). Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response. Gastroenterology. 117(5). 1187–1197. 66 indexed citations
9.
Ackrill, Andrew M., et al.. (1993). Specific deletions in the hepatitis B virus core open reading frame in patients with chronic active hepatitis B. Journal of Medical Virology. 41(2). 165–169. 27 indexed citations
10.
Ackrill, Andrew M., et al.. (1992). Comparison of pre-core/core hepatitis B virus region in liver tissue and serum from patients with chronic hepatitis B infection. Journal of Hepatology. 16(1-2). 224–227. 19 indexed citations
11.
Foster, Graham R., Andrew M. Ackrill, Robert Goldin, et al.. (1991). Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.. Proceedings of the National Academy of Sciences. 88(7). 2888–2892. 128 indexed citations
12.
Ackrill, Andrew M., Christopher S. Gilbert, Dirk R. Gewert, et al.. (1991). Differential response of the human 6–16 and 9–27 genes to α and γ interferons. Nucleic Acids Research. 19(3). 591–598. 38 indexed citations
13.
Ackrill, Andrew M., Graham R. Foster, Carl Laxton, et al.. (1991). Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Research. 19(16). 4387–4393. 105 indexed citations
14.
Imam, A., Andrew M. Ackrill, Trevor Dale, Ian M. Kerr, & George R. Stark. (1990). Transcription factors induced by interferons α and γ. Nucleic Acids Research. 18(22). 6573–6580. 72 indexed citations
15.
Ackrill, Andrew M. & G. Eric Blair. (1990). Interferon-γ regulation of major histocompatibility class i gene expression in rat cells containing the adenovirus 12 E1 a oncogene. Virology. 174(1). 325–328. 4 indexed citations
16.
17.
Ackrill, Andrew M. & G. Eric Blair. (1988). Expression of hamster MHC class I antigens in transformed cells and tumours induced by human adenoviruses. European Journal of Cancer and Clinical Oncology. 24(11). 1745–1750. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriyoshi Kuzushita Breakdown of academic impact, for papers by Bettina Langhans Breakdown of academic impact, for papers by Glenn B. Knight Breakdown of academic impact, for papers by Hideharu Harada Breakdown of academic impact, for papers by C. Bréchot Breakdown of academic impact, for papers by Seishin Azuma Breakdown of academic impact, for papers by A Alfarano Breakdown of academic impact, for papers by David Apelian Breakdown of academic impact, for papers by S. Koi Breakdown of academic impact, for papers by Nadia Alatrakchi
Rankless by CCL
2026